Uncategorized - malecare.org

Algeta, Completing A Successful Phase II Trial For Men With Bone Metastases Will Begin Enrolling US Survivors Into A Phase III Trial

Algeta ASA (OSE: ALGETA), has announced that it will begin to enroll US survivors into its Alsympca phase III trial evaluating Alpharadin (radium-223). Alpharadin is designed to be used as a treatment for bone metastases in prostate cancer survivors with hormone-refractory prostate cancer (HRPC). The announcement of the trial follows a successful end-of-phase II meeting [...]

By Malecare|2021-02-17T10:45:20-05:00February 4th, 2009|Advanced Prostate Cancer, Alpharadin (radium-223), Clinical Trials, Clinical Trials, Metastases, Research, Uncategorized, Understanding APC|0 Comments

Thalidomide and Intermittent ADT Effects PSA Progression

According to a study reported in the Journal of Urology, Thalidomide is associated with an increase in prostate specific antigen (PSA) progression-free survival in men with biochemically recurrent prostate cancer who are on intermittent androgen deprivation therapy (ADT). The study leader, Dr William Figg, from the National Institutes of Health in Bethesda, Maryland, said, "These [...]

By Malecare|2017-10-19T10:56:12-04:00February 3rd, 2009|Advanced Prostate Cancer, Uncategorized|0 Comments

A Clinical Trial : Ixabepilone, Mitoxantrone, and Prednisone in Treating Patients with Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy and Chemotherapy

I was recently reviewing current clinical trials and came across this one for men who have failed chemotherapy, what many of us view as the final treatment for advanced prostate cancer. It provides a potential opportunity to combine two different therapy agents (one old, mitoxantrone; one relatively new, ixabepilone). Both of these chemicals are known [...]

By Malecare|2020-02-04T10:11:12-05:00February 2nd, 2009|Advanced Prostate Cancer, Chemo Therapy, Chemo Therapy Failure, Clinical Trials, Clinical Trials, Uncategorized|7 Comments

The Role of BRCA1 and BRCA2 Gene Mutations in Advanced Prostate Cancer

Sure, we need more research about prostate cancer, but fortunately we also gain from research into other cancers. The commonly referred to breast cancer genes, BRCA1 and BRCA2 might also increase a man’s risk for developing an aggressive strain of prostate cancer. According to a report in Reuters, men with prostate cancer who also carry [...]

By Malecare|2017-10-19T10:56:20-04:00February 1st, 2009|Advanced Prostate Cancer, General Information, genetics, Prostate Ponderings, Research, Uncategorized, Understanding APC|0 Comments

Cancer is a Life-long Experience

Not only is having cancer a life changing experience, but it also is a life-long event. Once you have been diagnosed, even if you think that you are cured, you remain a cancer survivor until you die. Cancer is never cured it is only controlled. We all are constantly subject to having a recurrence and [...]

By Malecare|2017-10-19T10:56:21-04:00January 30th, 2009|Advanced Prostate Cancer, How We Live, Me, Personal Experiences, Uncategorized, Understanding APC|0 Comments